Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gelman Sciences was a prominent manufacturer of microfiltration products and membranes used in laboratory research, medical diagnostics, and industrial processes. Founded in 1958 in Ann Arbor, Michigan, the company became a global leader in developing microporous membranes for air and liquid filtration. Its technology was essential for sterile filtration in pharmaceutical manufacturing and laboratory analysis. In 1997, the company was acquired by Pall Corporation for approximately $280 million, which integrated Gelman's filtration expertise into its own life sciences division. Today, the company is also widely recognized for the long-term environmental remediation efforts associated with 1,4-dioxane groundwater contamination at its former headquarters.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gelman Sciences.